ArticleThe Lancet. Oncology2021

Neural stem cell delivery of an oncolytic adenovirus in newly diagnosed malignant glioma: a first-in-human, phase 1, dose-escalation trial.

Jawad Fares et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.